T2C-M 10/500 Tablet ER
Marketer
Ipca Laboratories Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview T2C-M 10/500 Tablet ER
Metformin/Sitagliptin Extended-Release tablets (10mg/500mg) are a dual-action medication for managing type 2 diabetes. They effectively lower elevated blood glucose, thereby mitigating the risk of severe diabetic complications and cardiovascular issues. This medication can be consumed with food and should be taken consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation should only occur under their guidance, as abrupt cessation can lead to dangerously high blood sugar levels and potentially serious consequences such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as prescribed by your doctor. Commonly reported side effects include pharyngitis, rhinitis, nasal congestion, cephalalgia, nausea, emesis, and diarrhea. Adequate hydration is crucial to prevent dehydration. Genital candidiasis may occur in some individuals; meticulous hygiene is recommended to minimize this risk. Prior to commencing treatment, inform your physician of any pre-existing renal or hepatic dysfunction, urinary tract infections, or diuretic use. Pregnant or lactating women should seek medical counsel before initiating treatment. Limit alcohol consumption to reduce the likelihood of intensified side effects. Regular blood glucose monitoring is essential during treatment.
Uses of T2C-M 10/500 Tablet ER
Managing Type 2 diabetes
Major Benefits of T2C-M 10/500 Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. The T2C-M 10/500 Extended-Release tablet should be taken with food.
Common Side effects of T2C-M 10/500 Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use T2C-M 10/500 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or break it. T2C-M 10/500 Extended-Release tablets should be administered with a meal.
How T2C-M 10/500 Tablet ER works:
T2C-M 10/500 Extended-Release tablets contain dapagliflozin and metformin, two medications that manage diabetes. Dapagliflozin eliminates excess glucose via urinary excretion. Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action facilitates superior glycemic management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol ingestion and T2C-M 10/500 Tablet ER is contraindicated due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release T2C-M 10/500 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release T2C-M 10/500 tablets are likely not safe for use while breastfeeding. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Extended-release T2C-M 10/500 tablets require careful administration in individuals with impaired renal function. Dosage modification for T2C-M 10/500 tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using T2C-M 10/500 Extended-Release tablets. Dosage modification of T2C-M 10/500 Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take T2C-M 10/500 Tablet ER :
Should you forget to take a T2C-M 10/500 Tablet ER, ingest it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Never take a double dose.
Facts to Know About T2C-M 10/500 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |






